ArticleFrontiers in immunology2022

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.

Chubei Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.